Loading stock data…
Akso Health Group (AHG)
$0.80-0.02 (-2.43%)
After Hours$0.82+0.02 (+1.99%)· Last close Sep 9
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Akso Health Group in the Healthcare sector is trading at $0.80 with a market capitalization of $1.3B. The stock is currently near its 52-week low of $0.80, remaining 49.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 33) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosme...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.25B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-1.01
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
932
Recent News
Akso Health Group (AHG) Is Up 8.2% After Auditor Flags Going Concern Risk Despite Narrower Losses
In July 2026, Akso Health Group reported full-year results for the period ended March 31, 2026, showing sales of US$13.84 million and a net loss of US$18.67 million, alongside materially lower loss per share than a year earlier. On the same date, auditor CHI-LLTC issued an unqualified opinion but raised substantial doubt about Akso Health Group’s ability to continue as a going concern, highlighting serious questions about its financial resilience despite narrowed losses. We’ll now examine...
While Akso Health Group (NASDAQ:AHG) shareholders have made 235% in 3 years, increasing losses might now be front of mind as stock sheds 10% this week
While Akso Health Group ( NASDAQ:AHG ) shareholders are probably generally happy, the stock hasn't had particularly...